Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/27765
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17109/19415 (88%)
Visitors : 2819165      Online Users : 245
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/27765


    Title: Abdominal Obesity Is Associated with Peripheral Artery Disease in Hemodialysis Patients
    Authors: Hung, Peir-Haur
    Tsai, Hung-Bin
    Lin, Chien-Hung
    Hung, Kuan-Yu
    Contributors: 生活應用與保健系
    Keywords: C-Reactive Protein
    Stage Renal-Disease
    Coronary-Heart-Disease
    Chronic Kidney-Disease
    Blood-Pressure Index
    Treatment Panel-Iii
    Metabolic Syndrome
    Cardiovascular Mortality
    Inflammatory Markers
    Occlusive Disease
    Date: 2013-06
    Issue Date: 2014-05-26 10:42:45 (UTC+8)
    Publisher: Public Library Science
    Abstract: Background: Peripheral arterial disease (PAD) is a leading cause of morbidity in hemodialysis (HD) patients. Recent evidence suggests that abdominal obesity (AO) may play a role in PAD. However, the association between AO and PAD has not been thoroughly studied in HD patients.Methods: The present cross-sectional study aimed to examine the relationship between AO and PAD in a cohort of 204 chronic HD patients. The ankle brachial index (ABI) was used as an estimate of the presence of PAD. Plasma adiponectin levels, interleukin-6 (IL-6) levels, high sensitivity C-reactive protein (hs-CRP) levels, asymmetric dimethylarginine (ADMA) levels, and lipid profiles were measured. Logistic regression was used to estimate the association between the presence of PAD and AO as well as other potential risk factors.Results: The metabolic risk factors and all individual traits, including elevated ln-transformed hs-CRP, were found to be significant (P<0.05) more frequently in HD patients with AO than that in control subjects. Patients with AO had a higher prevalence of PAD than the control individuals, with a mean ABI of 0.96 +/- 0.23 and 1.08 +/- 0.16 (P<0.0001) and PAD prevalence of 26.9% and 10.8% (P=0.003), respectively. By multivariate analysis, AO (odds ratio [OR], 4.532; 95% CI, 1.765-11.639; P=0.002), elevated serum ln-transformed ADMA (OR, 5.535; 95% CI, 1.323-23.155; P=0.019), and ln-transformed IL-6 (OR, 1.567; 95% CI, 1.033-2.378; P=0.035) were independent predictors of the presence of PAD.Conclusions: HD patients with AO exhibited a cluster of metabolic risk factors and lower ABI. AO, elevated serum lntransformed ADMA, and ln-transformed IL-6 were independent predictors of the presence of PAD.
    Appears in Collections:[Dept. of Applied Life Science and Health] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML835View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback